Skip to main content
The George Institute for Global HealthThe George Institute for Global Health
Covid-19 Covid 19 Covid 19
Donate

Social links India

  • Facebook
  • Twitter
  • YouTube
The George Institute for Global Health
  • About us
    • Our Mission And Values
    • Our Strategy
    • Our History
    • How Our Research Is Different
    • Our People
    • Board Of Directors
    • Global Advisory Committee (ACRIS)
    • George Health
    • Annual Reports
    • Financial Statements
    • Our Key Policies
  • Our Work
    • Our Priorities
    • Better Treatments
    • Better Care
    • Healthier Societies
    • Ongoing Projects
    • Projects by Our Affiliates
    • Archived Projects
    • Publications
  • News & Events
    • Media Releases
    • News Stories
    • Media Coverage
    • Media Enquiries
    • Events
    • Past Events
    • Blogs / Profile Stories
    • E-Newsletters
    • Videos
  • Our Impact
    • Advocacy And Thought Leadership
    • Disruptive Social Entrepreneurship
    • Policy statements and recommendations
    • Case Studies And Examples
    • Careers & studies
      • The George Experience
      • Current Job Opportunities
    • Contact Us
    • Get involved
        • Building Back Better After COVID-19: The Research Agenda
        • Reclaiming Comprehensive Public Health: A Call to Action
        • Clinical Trials
      • Donate
      1. Home
      2. Publications

      WCN23-0069 EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISOLONE IN IGA NEPHROPATHY: THE TESTING TRIAL

      Authors
      M Wong
      Type of Publication
      Journal Article
      Year of Publication
      2023
      Journal
      Kidney International Reports
      Language
      Eng
      Volume
      8
      Number of Pages
      S51 - S52
      Links to full text
      • Google Scholar
      • BibTeX
      • EndNote X3 XML
      • EndNote 7 XML
      • Endnote tagged
      • Marc
      • RIS
      Search Publications

      Latest Publications

      • E-cigarettes: A continuing public health challenge in India despite comprehensive bans

        Preventive Medicine Reports

        2023

      • WCN23-0200 PREVALENCE AND TREATMENT PATTERNS OF ANAEMIA IN INDIVIDUALS WITH CHRONIC KIDNEY DISEASE ACROSS ASIA

        Kidney International Reports

        2023

      • WCN23-0069 EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISOLONE IN IGA NEPHROPATHY: THE TESTING TRIAL

        Kidney International Reports

        2023

      • Outcomes in intervention research on snakebite envenomation: a systematic review

        F1000Research

        2022

      View all
      • About us
      • Our Work
      • News & Events
      • Our Impact
      • Careers & studies
      • Get involved
      • Thought leadership
      • Contact us
      • Donate

      The George Institute for Global Health

      308, Third Floor, Elegance Tower, Plot No. 8, Jasola District Centre
      New Delhi 110025 India
      Tel: +91 11 415 880 91-93
      Fax: +91 11 415 880 90
      info@georgeinstitute.org.in

      The George Institute country sites:

      • The George Institute country sites:
      • Australia
      • China
      • India
      • UK
      • In partnership with Manipal Academy of Higher Education

      Social links India

      • Facebook
      • Twitter
      • YouTube

      Subscribe to our E-newsletter

      Copyright © 2023 The George Institute

      Footer Links

      • Disclaimer
      • Privacy policy
      • Data sharing policy
      • Whistleblower policy
      • Modern slavery statement
      • Research code policy
      • PHS awards financial COI policy
      • Sitemap
      Please register to download the report
      ×

      Thank you for your interest in the FoodSwitch – State of the Food Supply Report 2022

      You should receive an email with a link to download the report.

      If you don't see it in your inbox, please check you spam folder in case it has been held there.

      Please enter a valid email address
      @Sarika - we need a title here
      ×